Used in pharmaceutical research as a potent adenosine receptor antagonist, particularly showing high affinity for the A2A adenosine receptor subtype. This compound is investigated for its potential in treating neurodegenerative disorders such as Parkinson’s disease, where modulation of adenosine receptors helps improve motor function. It also exhibits anti-inflammatory properties, making it a candidate for development in immune-related conditions. Due to its ability to cross the blood-brain barrier effectively, it is valued in central nervous system drug design. Additionally, it serves as a chemical probe in biochemical assays to study receptor binding and signaling pathways.